Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""RNA, Messenger genetics"" wg kryterium: Temat


Tytuł :
Exosomal Expression of CXCR4 Targets Cardioprotective Vesicles to Myocardial Infarction and Improves Outcome after Systemic Administration
Autorzy :
Ciullo, Alessandra
Biemmi, Vanessa
Milano, Giuseppina
Bolis, Sara
Cervio, Elisabetta
Fertig, Emanuel Tudor
Gherghiceanu, Mihaela
Moccetti, Tiziano
Camici, Giovanni G
Vassalli, Giuseppe
Barile, Lucio
Pokaż więcej
Temat :
Chemistry
610 Medicine & health
QD1-999
Cardiocentro Ticino
Article
QH301-705.5
cardiac progenitor cells
carbohydrates (lipids)
fungi
exosomes
macromolecular substances
Animals
Blotting, Western
Cell Survival/drug effects
Cell Survival/genetics
Cell Survival/physiology
Cells, Cultured
Chemokine CXCL12/genetics
Chemokine CXCL12/metabolism
Cryoelectron Microscopy
Enzyme-Linked Immunosorbent Assay
Exosomes/metabolism
Flow Cytometry
Fluorescent Antibody Technique
Heterocyclic Compounds/therapeutic use
Humans
Male
Myocardial Infarction/genetics
Myocardial Infarction/metabolism
Myocardial Infarction/therapy
RNA, Messenger/genetics
RNA, Messenger/metabolism
Rats
Rats, Wistar
Receptors, CXCR4/antagonists & inhibitors
Receptors, CXCR4/genetics
Receptors, CXCR4/metabolism
CXCR4
intravenous injection
Clinic for Cardiology
Biology (General)
Źródło :
Ciullo, Alessandra; Biemmi, Vanessa; Milano, Giuseppina; Bolis, Sara; Cervio, Elisabetta; Fertig, Emanuel Tudor; Gherghiceanu, Mihaela; Moccetti, Tiziano; Camici, Giovanni G; Vassalli, Giuseppe; Barile, Lucio (2019). Exosomal Expression of CXCR4 Targets Cardioprotective Vesicles to Myocardial Infarction and Improves Outcome after Systemic Administration. International Journal of Molecular Sciences, 20(3):E468.
International Journal of Molecular Sciences
International journal of molecular sciences, vol. 20, no. 3
International Journal of Molecular Sciences, Vol 20, Iss 3, p 468 (2019)
Opis pliku :
application/pdf
Tytuł :
Low-frequency variation in TP53 has large effects on head circumference and intracranial volume
Autorzy :
Haworth, Simon
Shapland, Chin Yang
Hayward, Caroline
Prins, Bram P.
Felix, Janine F.
Medina-Gomez, Carolina
Rivadeneira, Fernando
Wang, Carol
Ahluwalia, Tarunveer S.
Vrijheid, Martine
Guxens, Mònica
Sunyer, Jordi
Tachmazidou, Ioanna
Walter, Klaudia
Iotchkova, Valentina
Jackson, Andrew
Cleal, Louise
Huffmann, Jennifer
Min, Josine L.
Sass, Lærke
Timmers, Paul R.H.J.
Davey Smith, George
Cole, Tim J.
Timpson, Nicholas
Zeggini, Eleftheria
St Pourcain, Beate
Pokaż więcej
Temat :
Adolescent
Adult
Aged
Aged, 80 and over
Alleles
Cephalometry
Child
European Continental Ancestry Group
Female
Gene Expression Regulation, Developmental
Gene Frequency
Genetic Loci
Genetic Variation
Genome, Human
Humans
Male
Middle Aged
RNA, Messenger/genetics
Skull/anatomy & histology
Tumor Suppressor Protein p53/genetics
Journal Article
Research Support, Non-U.S. Gov't
Źródło :
Haworth, S, Shapland, C Y, Hayward, C, Prins, B P, Felix, J F, Medina-Gomez, C, Rivadeneira, F, Wang, C, Ahluwalia, T S, Vrijheid, M, Guxens, M, Sunyer, J, Tachmazidou, I, Walter, K, Iotchkova, V, Jackson, A, Cleal, L, Huffmann, J, Min, J L, Sass, L, Timmers, P R H J, Davey Smith, G, Cole, T J, Timpson, N & Zeggini, E & St Pourcain, B 2019, ' Low-frequency variation in TP53 has large effects on head circumference and intracranial volume ', Nature Communications, vol. 10, 357 . https://doi.org/10.1038/s41467-018-07863-x
Opis pliku :
application/pdf
Tytuł :
Long-Term Vemurafenib Exposure Induced Alterations of Cell Phenotypes in Melanoma:Increased Cell Migration and Its Association with EGFR Expression
Autorzy :
Molnár, Eszter
Garay, Tamás
Donia, Marco
Baranyi, Marcell
Rittler, Dominika
Berger, Walter
Tímár, József
Grusch, Michael
Hegedűs, Balázs
Pokaż więcej
Temat :
Adult
Aged
Cell Line, Tumor
Cell Movement/drug effects
Cell Proliferation/drug effects
Drug Resistance, Neoplasm/drug effects
Epithelial-Mesenchymal Transition/drug effects
ErbB Receptors/metabolism
Erlotinib Hydrochloride/pharmacology
Female
Gene Expression Regulation, Neoplastic/drug effects
Humans
Inhibitory Concentration 50
Male
Melanoma/drug therapy
Middle Aged
Mutation/genetics
Neoplasm Proteins/genetics
Phenotype
Proto-Oncogene Proteins B-raf/genetics
RNA, Messenger/genetics
Signal Transduction/drug effects
Time Factors
Vemurafenib/pharmacology
Journal Article
Źródło :
Molnár, E, Garay, T, Donia, M, Baranyi, M, Rittler, D, Berger, W, Tímár, J, Grusch, M & Hegedűs, B 2019, ' Long-Term Vemurafenib Exposure Induced Alterations of Cell Phenotypes in Melanoma : Increased Cell Migration and Its Association with EGFR Expression ', International Journal of Molecular Sciences, vol. 20, no. 18, 4484 . https://doi.org/10.3390/ijms20184484
Opis pliku :
application/pdf
Tytuł :
Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded study
Autorzy :
Buhl, Anna Sofie Kappel
Christensen, Troels Dreier
Christensen, Ib Jarle
Nelausen, Knud Mejer
Balslev, Eva
Knoop, Ann Søegaard
Brix, Eva Harder
Svensson, Else
Glavicic, Vesna
Luczak, Adam
Langkjer, Sven Tyge
Linnet, Søren
Jakobsen, Erik Hugger
Bogovic, Jurij
Ejlertsen, Bent
Rasmussen, Annie
Hansen, Anker
Knudsen, Steen
Nielsen, Dorte
Jensen, Peter Buhl
Pokaż więcej
Temat :
Retrospective Studies
Clinical Trial
Aged
RNA, Messenger/genetics
Epirubicin
Gene Expression Regulation, Neoplastic/drug effects
Breast Neoplasms/drug therapy
Disease Progression
Middle Aged
Epirubicin/administration & dosage
Biomarkers, Pharmacological
Disease-Free Survival
Prospective Studies
Precision medicine
Journal Article
Predictive biomarker
Advanced breast cancer
Adult
Female
Humans
Neoplasm Proteins/genetics
Proportional Hazards Models
Źródło :
Buhl, A S K, Christensen, T D, Christensen, I J, Nelausen, K M, Balslev, E, Knoop, A S, Brix, E H, Svensson, E, Glavicic, V, Luczak, A, Langkjer, S T, Linnet, S, Jakobsen, E H, Bogovic, J, Ejlertsen, B, Rasmussen, A, Hansen, A, Knudsen, S, Nielsen, D & Jensen, P B 2018, ' Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort : a retrospective-prospective blinded study ', Breast Cancer Research and Treatment, vol. 172, no. 2, pp. 391–400 . https://doi.org/10.1007/s10549-018-4918-4
Buhl, A S K, Christensen, T D, Christensen, I J, Nelausen, K M, Balslev, E, Knoop, A S, Brix, E H, Svensson, E, Glavicic, V, Luczak, A, Langkjer, S T, Linnet, S, Jakobsen, E H, Bogovic, J, Ejlertsen, B, Rasmussen, A, Hansen, A, Knudsen, S, Nielsen, D & Jensen, P B 2018, ' Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort : a retrospective-prospective blinded study ' Breast Cancer Research and Treatment, vol. 172, no. 2, pp. 391–400 . https://doi.org/10.1007/s10549-018-4918-4
Buhl, A S K, Christensen, T D, Christensen, I J, Nelausen, K M, Balslev, E, Knoop, A S, Brix, E H, Svensson, E, Glavicic, V, Luczak, A, Langkjer, S T, Linnet, S, Jakobsen, E H, Bogovic, J, Ejlertsen, B, Rasmussen, A, Hansen, A, Knudsen, S, Nielsen, D & Jensen, P B 2018, ' Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort : a retrospective-prospective blinded study ', Breast Cancer Research and Treatment, vol. 172, no. 2, pp. 391-400 . https://doi.org/10.1007/s10549-018-4918-4
Breast Cancer Research and Treatment
Opis pliku :
application/pdf
Tytuł :
De Novo and inherited loss-of-function variants in TLK2: Clinical and genotype-phenotype evaluation of a distinct neurodevelopmental disorder
Autorzy :
Reijnders, Margot R.F.
Miller, Kerry A.
Alvi, Mohsan
Goos, Jacqueline A.C.
Lees, Melissa M.
de Burca, Anna
Henderson, Alex
Kraus, Alison
Mikat, Barbara
de Vries, Bert B.A.
Isidor, Bertrand
Kerr, Bronwyn
Marcelis, Carlo
Schluth-Bolard, Caroline
Deshpande, Charu
Ruivenkamp, Claudia A.L.
Wieczorek, Dagmar
Baralle, Diana
Blair, Edward M.
Engels, Hartmut
Lüdecke, Hermann Josef
Eason, Jacqueline
Santen, Gijs W.E.
Clayton-Smith, Jill
Chandler, Kate
Tatton-Brown, Katrina
Payne, Katelyn
Helbig, Katherine
Radtke, Kelly
Nugent, Kimberly M.
Cremer, Kirsten
Strom, Tim M.
Bird, Lynne M.
Sinnema, Margje
Bitner-Glindzicz, Maria
van Dooren, Marieke F.
Alders, Marielle
Koopmans, Marije
Brick, Lauren
Kozenko, Mariya
Harline, Megan L.
Klaassens, Merel
Steinraths, Michelle
Cooper, Nicola S.
Edery, Patrick
Yap, Patrick
Terhal, Paulien A.
Taylor, Rachel L.
McLean, Scott
Douzgou, Sofia
Pokaż więcej
Temat :
Translocation, Genetic
no
RNA, Messenger/genetics
Young Adult
Infant
Inheritance Patterns/genetics
Genetics
MUTATIONS
Base Sequence
Facies
Female
facial averaging
Cell Line
Child, Preschool
Neurodevelopmental Disorders/genetics
Genetics(clinical)
GENES
Protein Kinases/genetics
Loss of Function Mutation/genetics
Tousled-like
kinase
TOUSLED-LIKE KINASES
haploinsufficiency
Adolescent
Genetic Association Studies
Adult
Humans
intellectual disability
Male
Child
Źródło :
American journal of human genetics, 102(6), 1195 - 1203. Cell Press
American Journal of Human Genetics, 102(6), 1195. Cell Press
The Deciphering Developmental Disorders Study, Kerr, B, Clayton-Smith, J, Chandler, K & Taylor, R L 2018, ' De Novo and Inherited Loss-of-Function Variants in TLK2 : Clinical and Genotype-Phenotype Evaluation of a Distinct Neurodevelopmental Disorder ', American Journal of Human Genetics, vol. 102, no. 6, pp. 1195-1203 . https://doi.org/10.1016/j.ajhg.2018.04.014
American Journal of Human Genetics, 102(6), 1195 - 1203. Cell Press
Opis pliku :
image/pdf; application/pdf; text
Tytuł :
The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity
Autorzy :
Colombo, Mara
Dennis, Joseph
Michailidou, Kyriaki
Wang, Qin
Brenner, Hermann
Cox, Angela
Eriksson, Mikael
Fletcher, Olivia
Gabrielson, Marike
González-Neira, Anna
Guénel, Pascal
Jakubowska, Anna
Jung, Audrey
Peterlongo, Paolo
Pylkäs, Katri
Southey, Melissa C
Swerdlow, Anthony
Truong, Thérèse
Dunning, Alison
Easton, Douglas
Antoniou, Antonis
Lòpez-Perolio, Irene
Meeks, Huong D
Caleca, Laura
Parsons, Michael T
Li, Hongyan
De Vecchi, Giovanna
Tudini, Emma
Foglia, Claudia
Mondini, Patrizia
Manoukian, Siranoush
Behar, Raquel
Garcia, Encarna B Gómez
Meindl, Alfons
Montagna, Marco
Niederacher, Dieter
Schmidt, Ane Y
Varesco, Liliana
Wappenschmidt, Barbara
Bolla, Manjeet K
Aittomäki, Kristiina
Andrulis, Irene L
Anton-Culver, Hoda
Arndt, Volker
Beckmann, Matthias W
Beeghly-Fadel, Alicia
Benitez, Javier
Boeckx, Bram
Bogdanova, Natalia V
Bojesen, Stig E
Bonanni, Bernardo
Brauch, Hiltrud
Burwinkel, Barbara
Chang-Claude, Jenny
Conroy, Don M
Couch, Fergus J
Cross, Simon S
Czene, Kamila
Devilee, Peter
Dörk, Thilo
Fasching, Peter A
Figueroa, Jonine
Flyger, Henrik
García-Closas, Montserrat
Giles, Graham G
Haiman, Christopher A
Hall, Per
Hamann, Ute
Hartman, Mikael
Hauke, Jan
Hollestelle, Antoinette
Hopper, John L
Kosma, Veli-Matti
Lambrechts, Diether
Le Marchand, Loid
Lindblom, Annika
Lubinski, Jan
Mannermaa, Arto
Margolin, Sara
Miao, Hui
Milne, Roger L
Neuhausen, Susan L
Nevanlinna, Heli
Olson, Janet E
Peto, Julian
Sawyer, Elinor J
Schmidt, Marjanka K
Schmutzler, Rita K
Schneeweiss, Andreas
Schoemaker, Minouk J
See, Mee Hoong
Teo, Soo H
Toland, Amanda E
Tomlinson, Ian
Van Asperen, Christi J
Van Den Ouweland, Ans MW
Van Der Kolk, Lizet E
Winqvist, Robert
Yannoukakos, Drakoulis
Zheng, Wei
KConFab/AOCS Investigators
Henderson, Alex
Hogervorst, Frans BL
Izatt, Louise
Offitt, Kenneth
Side, Lucy E
Van Rensburg, Elizabeth J
Embrace, Study
Hebon, Study
McGuffog, Lesley
Chenevix-Trench, Georgia
Spurdle, Amanda B
Goldgar, David E
Hoya, Miguel De La
Radice, Paolo
Pokaż więcej
Temat :
FANCONI-ANEMIA
Exons/genetics
BRCA2 Protein
RNA, Messenger/genetics
multifactorial likelihood analysis
BRCA2 Protein/genetics
quantitative real-time PCR
Models, Genetic
Research Support, Non-U.S. Gov't
spliceogenic variants
MUTATIONS
3111 Biomedicine
Mitomycin
RNA, Messenger
SEQUENCE VARIANTS
Base Sequence
Female
Calibration
Cell Line
Mitomycin/pharmacology
BRCA2
UNCLASSIFIED VARIANTS
digital PCR
RNA
GENES
Exons
Genetic Variation
RNA Splicing
kConFab/AOCS Investigators
INTEGRATED EVALUATION
Journal Article
CANCER
RISK
Genetic Predisposition to Disease
RNA Splicing/genetics
Humans
BREAST
Źródło :
kConFab/AOCS Investigators 2018, ' The BRCA2 c.68-7T > A variant is not pathogenic : A model for clinical calibration of spliceogenicity ', Human Mutation, vol. 39, no. 5, pp. 729-741 . https://doi.org/10.1002/humu.23411
Colombo, M; Lòpez-Perolio, I; Meeks, HD; Caleca, L; Parsons, MT; Li, H; et al.(2018). The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity.. Human mutation, 39(5), 729 - 741. doi: 10.1002/humu.23411. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/4zx2r18x
Human Mutation, 39(5), 729 - 741. Wiley
Opis pliku :
application/pdf; Print-Electronic

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies